Concord Drugs Q4 Results
- BSE: 538965
- NSE: -
- ISIN: INE858L01010
- Sector: Biotechnology & Drugs
BSE
78.56
-1.11 (-1.39%)
-1.11 (-1.39%)Volume6.71 K
Updated: Tue 15 Sep, 2026 | 15:26:56
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Concord Drugs Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 36.76 | 16.35 | 124.78% | 15.69 | 277.85% |
| Depreciation/ Amortization | 0.35 | 0.31 | 15.03% | 0.39 | -6.59% |
| Operating Income | 1.13 | 0.61 | 84.28% | -0.04 | 70.52% |
| Net Income | 0.53 | 0.22 | 143.48% | -0.34 | 1257.58% |
| Other Operating Expenses Total | 0.53 | 0.42 | 27.77% | 0.35 | 159.41% |
| Net Income Before Taxes | 0.75 | 0.30 | 152.52% | -0.55 | 1189.14% |
| Total Revenue | 37.89 | 16.97 | 123.31% | 15.64 | 264.60% |
| Selling/ General/ Admin Expenses Total | 1.75 | 1.24 | 41.65% | 1.69 | 41.53% |
| Diluted Normalized EPS | 0.47 | 0.16 | 193.75% | -0.34 | 1140.76% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.